ImmunoPrecise Antibodies Ltd.
IPA
$3.20
$0.5721.67%
NASDAQ
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -21.45M | -32.91M | -19.75M | -19.66M | -19.30M |
| Total Depreciation and Amortization | 3.64M | 3.99M | 3.99M | 3.96M | 4.08M |
| Total Amortization of Deferred Charges | 38.30K | 211.50K | 198.80K | 185.60K | 173.20K |
| Total Other Non-Cash Items | 12.88M | 23.29M | 10.07M | 10.15M | 10.93M |
| Change in Net Operating Assets | 271.50K | 431.80K | 588.90K | 2.08M | 1.76M |
| Cash from Operations | -4.62M | -4.99M | -4.90M | -3.27M | -2.36M |
| Capital Expenditure | -571.10K | -1.15M | -948.00K | -1.12M | -1.03M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 0.00 | 0.00 | 0.00 | -109.40K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 11.80K | -68.20K | -77.80K | -14.10K |
| Cash from Investing | -571.10K | -1.14M | -1.02M | -1.20M | -1.15M |
| Total Debt Issued | 4.24M | 4.24M | 4.06M | 2.60M | -- |
| Total Debt Repaid | -1.58M | -1.44M | -1.43M | -1.33M | -1.34M |
| Issuance of Common Stock | 12.23M | 13.64M | 3.87M | 2.85M | 2.36M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 10.61M | 11.73M | 4.77M | 3.02M | 749.70K |
| Foreign Exchange rate Adjustments | -316.30K | -973.20K | -675.70K | -624.00K | -809.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.10M | 4.64M | -1.83M | -2.08M | -3.57M |